a public good project by the
Synthesis
Company
of California

© 2026

Simona Volpi | doi.page

0 works0 citations0 h-index

Simona Volpi

National Institutes of Health(US)National Human Genome Research Institute(US)

Publications by Year

Research Areas

Genetic Associations and Epidemiology, Neuroendocrine regulation and behavior, Genomics and Rare Diseases, Bioinformatics and Genomic Networks, Genomics and Chromatin Dynamics

Most-Cited Works

→ Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multicenter Pilot for Preemptive Pharmacogenomics in Electronic Health Record Systems(2014)242 cited
→ Applicability of a Genetic Signature for Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia(2009)205 cited
→ Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network(2016)186 cited
→ Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study(2008)154 cited
→ Vasopressinergic Regulation of the Hypothalamic Pituitary Adrenal Axis and Stress Adaptation(2004)135 cited
→ Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects(2018)130 cited

→ Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia(2008)

104 cited

→ HIV-1 Protein Vpr Suppresses IL-12 Production from Human Monocytes by Enhancing Glucocorticoid Action: Potential Implications of Vpr Coactivator Activity for the Innate and Cellular Immunity Deficits Observed in HIV-1 Infection(2002)90 cited

→ Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress(2007)84 cited

→ Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia(2009)83 cited